Giga Compounds Review: COAs, Pricing Tiers, Testing, and What We Found

An independent evidence review of Giga Compounds covering its 34 public certificate PDFs, rejected-batch history, pricing tiers, shipping terms, and important testing caveats.

---

Giga Compounds is now a curated vendor on PeptideBenchmark. The reason is not a testimonial or a broad “third-party tested” claim. It is the amount of public material we could inspect: a stock-aware catalog, anonymous-cart discount behavior, and a certificate library that leaves failed batches visible instead of presenting only favorable results.

This review explains what held up, what did not, and why the distinction between a real certificate and a verified current-product relationship still matters.

The short version

Giga has a stronger public evidence surface than a storefront that displays one favorable COA per compound. We captured 34 distinct PDF reports across Janoshik Analytical, Kovera Labs, and Chromate. The library retains 22 active, four depleted, one pending, and seven rejected reports.

That rejected-batch history is a meaningful transparency positive. For example, the library continues to expose reports whose summaries say an endotoxin result was above standard. A vendor that preserves an unfavorable document gives readers more information than one that quietly removes it.

The limits are equally important. Twelve additional library rows were placeholders without a downloadable document. Five of the 34 source PDFs (July 28 snapshot) did not map cleanly to a current catalog product. Several current results show meaningful net-content variance. And a published lab link is not enough on its own — PeptideBenchmark only marks a report provider-verified when that specific lab page checks out (see the Aug 12 update above for the current count).

What we found in the catalog

Our current discovery pass found:

Catalog result	Count	What it means
Public products	37	Full current product payload
In stock	19	Product presently reports orderable inventory
Pricing-ready vial products	16	In-stock, mg-normalized offers promoted to Pricing and Stack Builder
Out of stock	18	Suppressed from current comparisons automatically
Support supplies	3	Retained for coverage, excluded from peptide-vial comparisons

The distinction matters. A historical COA can remain useful evidence even when its product is unavailable, while an out-of-stock product should not appear as a purchasable “best price.”

Current normalized offers are available on PeptideBenchmark Pricing, and multi-vial requirements can be modeled in the Stack Builder. Those tools refresh from the live product payload; the counts in this article are a dated snapshot.

Outside review signal

Giga also has a claimed Trustpilot profile. On July 28, 2026, the profile showed a 4.6 TrustScore from 25 reviews. Trustpilot labels the business as asking customers for reviews, and its public breakdown showed all 25 reviews within the prior 12 months.

That is useful outside feedback, but it answers a different question from laboratory evidence. Customer reviews can inform fulfillment, communication, and service history; they do not independently establish the contents of a vial or validate a certificate. PeptideBenchmark therefore treats the Trustpilot signal separately from COA coverage and provider verification.

The certificate library: current, historical, and rejected

Giga’s public lab-test library exposed 46 batch rows:

• 34 downloadable PDF objects
• 12 placeholders without a document
• 22 active reports
• 4 depleted reports
• 1 pending report
• 7 rejected reports

PeptideBenchmark preserves each real PDF with a SHA-256 fingerprint, the original source route, batch status, document-extracted fields, product relationship, panel summary, and any attributable laboratory-verification route. Browse the underlying records in the Giga Compounds COA results.

Rejected and depleted do not mean the same thing. “Depleted” describes batch availability. “Rejected” is an adverse quality status. Neither should be silently relabeled as current-batch support simply because the report remains public.

Why preserving failed results matters

The reviewed history includes rejected reports with elevated endotoxin values. One NAD+ 500mg report is explicitly summarized as “Endotoxin ABOVE STANDARD. Batch REJECTED.” Other rejected entries include GHK-Cu, IGF-1 LR3, and SS-31 records with unfavorable reported results.

We do not present those as evidence that the current batch failed. We present them as evidence that:

1. the tested historical sample had the stated result;
2. the vendor classified the batch as rejected; and
3. the public history did not erase the document.

That is exactly why the COA database separates document history from current-product evidence.

Which panels appeared?

Across the 34 retained PDFs, the structured pass identified:

Panel	Certificates reporting it
HPLC / purity	33
Identity	33
Net content	31
Endotoxin	25
Sterility or microbial testing	3
Heavy metals	2

Panel counts are not interchangeable. HPLC purity does not establish sterility. Identity does not establish endotoxin. A certificate with more panels is not automatically evidence that every retail unit has the same condition.

The laboratory attribution also varies: our extraction identified 29 Janoshik, four Kovera, and one Chromate document. Lab names are preserved from the document; provider verification is a separate field.

Provider links: published is not the same as independently resolved

Some Giga rows publish exact outside-laboratory routes. PB checks those routes rather than awarding a badge from the laboratory logo alone.

As of the Aug 12, 2026 refresh:

• 10 Janoshik reports check out on Janoshik’s own verify pages;
• 1 Kovera report checks out on Kovera’s verify page;
• several other named-lab PDFs remain useful vendor-hosted documents without a working lab lookup; and
• one row still points only to Janoshik’s generic verify page, which cannot identify a specific report.

The conservative rule is unchanged. A named-lab PDF on the vendor’s site can still be useful evidence. It simply should not be labeled “provider verified” until the specific lab link checks out.

Net-content variance deserves attention

Several retained results differ materially from the product label. Examples in the current public library include:

• GHK-Cu 100mg: 83.31mg reported net content
• GHK-Cu 50mg: 43.59mg reported net content
• SS-31 10mg: 9.62mg reported net content

PeptideBenchmark preserves the labeled and measured values separately and lets the anomaly layer compare them. A high HPLC purity result cannot compensate for a quantity shortfall; those are different measurements.

These are certificate-level observations, not claims about every unit. Readers should open the exact record, confirm the batch status and product relationship, and inspect the source document before drawing a conclusion.

Pricing: automatic 15%, then same-product tiers

Giga’s pricing model is more layered than the displayed product price suggests. The anonymous-cart pass found:

1. an automatic 15% adjustment to merchandise;
2. a further 10% off at three of the same product;
3. 17.5% off at five of the same product; and
4. 35% off at ten of the same product.

The tier applies to the same SKU/product rather than a mixed cart and follows the 15% automatic adjustment. PB stores the standing price and models the two verified layers separately, which makes the savings breakdown auditable.

Two Tesamorelin products also exposed a public buy-three-get-one configuration flag. An isolated three-unit guest cart did not add a free line, so PB captures the claim but does not use it in Pricing or Stack Builder math. The same fail-closed treatment applies to the advertised 5% crypto discount until its exact payment and stacking behavior is completed.

Shipping and rewards

The storefront and policy surface publish free U.S. shipping over $200, calculated after merchandise discounts and before tax. Giga also states that:

• fulfillment runs Monday through Friday until 2 PM EST;
• orders ship via FedEx 2-Day from its temperature-controlled, secure facility in Virginia; and
• orders placed after 2 PM EST on Friday ship Monday.

These are vendor-published operational claims observed on July 28, 2026, not an independent inspection of the facility or a delivery-time guarantee. The Virginia fulfillment statement is also distinct from the Wyoming postal address in Giga’s public organization schema. Shipping remains outside normalized item-price rankings because destination and checkout state can change the final total.

Giga also advertises GigaWallet rewards. Store credit is not treated as an immediate cash discount: a future-use balance is not the same thing as paying less for the current order.

Why Giga is curated

Curated does not mean endorsed. It means PeptideBenchmark has done enough work to maintain a structured, reviewable record:

• current catalog and stock discovery;
• normalized price rows;
• cart-tested discount composition;
• a public, fingerprinted COA archive;
• exact product relationships where supportable;
• retained rejected and depleted history;
• panel-level extraction and anomaly checks; and
• a dedicated regression suite that fails if the evidence surface collapses.

The live Giga Compounds profile carries the current score and trust band. The scoring model rewards the public documents and unusual rejected-batch transparency while keeping provider accessibility, coverage, panel depth, anomalies, and outside corroboration separate.

Bottom line

Giga Compounds earned curated coverage because its public evidence was substantial enough to preserve and challenge. The strongest feature is not a single high purity number—it is a batch archive that includes unfavorable outcomes. The most important limitations are provider-route accessibility, placeholder rows, incomplete current-product matching, and meaningful quantity variance in several reports.

That is a useful record, not a safety verdict. Readers can inspect the Giga vendor profile, search the archived COAs, compare current prices, check the coupon / referral page, and open the official storefront directly.

Common questions

Is Giga Compounds legitimate?

PeptideBenchmark does not issue binary legitimacy or product-safety endorsements. We confirmed a public 37-product storefront, anonymous-cart discount behavior, and 34 downloadable certificate PDFs associated with Giga products. Those facts support an inspectable vendor record, but they do not independently establish the identity, condition, or safety of a physical vial.

Does Giga Compounds publish COAs?

Yes. In the July 28, 2026 review, Giga's public lab library exposed 34 downloadable certificate PDFs plus 12 placeholder rows without documents. The retained PDFs included active, depleted, pending, and rejected batch records.

Are Giga Compounds COAs independently verifiable?

Some publish exact Janoshik or Kovera verify links. PeptideBenchmark marks a report provider-verified only when that specific lab link checks out. As of the Aug 12, 2026 refresh, 10 Janoshik reports and 1 Kovera report resolve at the lab (11 of 38 retained PDFs). One library row still links only to Janoshik’s generic verify page, which cannot identify a specific report.

What quantity discounts does Giga Compounds offer?

The July 28 anonymous-cart review found an automatic 15% adjustment followed by same-product tiers of 10% at three units, 17.5% at five, and 35% at ten. Those terms are modeled as a dated commercial snapshot and can change.

Where does Giga Compounds ship from?

Giga states that it fulfills orders in-house from a temperature-controlled, secure facility in Virginia and uses FedEx 2-Day. Its public organization schema separately lists a Wyoming postal address; PeptideBenchmark treats the postal and fulfillment locations as different vendor-stated facts.

Does PeptideBenchmark have an affiliate relationship with Giga Compounds?

Not at the July 28, 2026 review date. As of August 12, 2026, PeptideBenchmark has a disclosed affiliate relationship with Giga Compounds. Referred shoppers get 10% off through the ?ref=GC-X065C link; that relationship does not change the evidence findings in this review.